Point72 Asset Management’s Olema Pharmaceuticals OLMA Stock Holding History

Point72 Asset Management’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.06M	Sell	71,107 -236,783	-77%	-$5.27M	﹤0.01%	2729
2025 Q4	$7.7M	Buy	307,890 +62,472	+25%	+$1.11M	0.01%	1518
2025 Q3	$2.4M	Buy	+245,418	New	+$1.47M	﹤0.01%	1356
2025 Q2	–	Sell	-1,441,690	Closed	-$5.42M	–	2484
2025 Q1	$5.42M	Sell	1,441,690 -2,229,136	-61%	-$11.2M	0.01%	897
2024 Q4	$21.4M	Sell	3,670,826 -16,548	-0.4%	-$165K	0.05%	425
2024 Q3	$44M	Buy	3,687,374 +475,447	+15%	+$6.08M	0.11%	212
2024 Q2	$34.8M	Buy	+3,211,927	New	+$34.8M	0.09%	288
2021 Q3	–	Sell	-80,000	Closed	-$2.24M	–	1185
2021 Q2	$2.24M	Sell	80,000 -13,900	-15%	-$396K	0.01%	717
2021 Q1	$3.12M	Buy	+93,900	New	+$4.02M	0.01%	664

Other funds holding OLMA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Point72 Asset Management's OLMA Position: Q1 2026 in Review

Point72 Asset Management reduced its Olema Pharmaceuticals (OLMA) stake by 77% in Q1 2026, selling an estimated $5.27M and leaving 71,107 shares worth $1.06M. The position accounts for ﹤0.01% of the portfolio, ranked #2729.

Point72 Asset Management first reported a position in OLMA in Q1 2021 and has held it in 9 quarters since. The position peaked at $44M in Q3 2024. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

Point72 Asset Management held 71,107 shares of Olema Pharmaceuticals worth $1.06M as of Q1 2026.
Point72 Asset Management sold 236,783 Olema Pharmaceuticals shares in Q1 2026, an estimated $5.27M.
Olema Pharmaceuticals made up ﹤0.01% of Point72 Asset Management's portfolio in Q1 2026, its #2729 holding.
Point72 Asset Management first reported a position in Olema Pharmaceuticals in Q1 2021 and has held it in 9 quarters since.
Point72 Asset Management's Olema Pharmaceuticals position peaked at $44M in Q3 2024.
195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.